Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR
Public ClinicalTrials.gov record NCT00043888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIIb/IV, Randomized, Open Label, Multicenter, Pilot Trial to Explore the Safety and Tolerability of GW433908 +/- Ritonavir (1400mg Twice Daily or 700mg/100mg Twice Daily) When Used in Combination With a Zidovudine-containing Regimen (TRIZIVIR or COMBIVIR Twice Daily) Over a 24 Week Period in Antiretroviral Therapy Naive HIV-1 Infected Subjects.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Antiretroviral Therapy (ART) naive subjects will be enrolled in this clinical research study to test the safety and tolerability of fosamprenavir with or without ritonavir in combination TRIZIVIR and COMBIVIR. Subjects will receive 24 weeks of therapy.
Study identification
- NCT ID
- NCT00043888
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2002 (Type not available)
- Primary completion
- May 2003 (Actual)
- Completion
- May 2003 (Actual)
- Last update posted
- Feb 12, 2013
2002 – 2003
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Clinical Trials Call Center | Little Rock | Arkansas | 72205 | — |
| GSK Clinical Trials Call Center | Long Beach | California | 90813 | — |
| GSK Clinical Trials Call Center | Newport Beach | California | 92663 | — |
| GSK Clinical Trials Call Center | San Diego | California | 92101 | — |
| GSK Clinical Trials Call Center | Denver | Colorado | 80220 | — |
| GSK Clinical Trials Call Center | Washington D.C. | District of Columbia | 20036 | — |
| GSK Clinical Trials Call Center | Altamonte Springs | Florida | 32701 | — |
| GSK Clinical Trials Call Center | Fort Lauderdale | Florida | 33308 | — |
| GSK Clinical Trials Call Center | Fort Lauderdale | Florida | 33316 | — |
| GSK Clinical Trials Call Center | Fort Lauderdale | Florida | 33334 | — |
| GSK Clinical Trials Call Center | Atlanta | Georgia | 30339 | — |
| GSK Clinical Trials Call Center | Greenville | North Carolina | 27858 | — |
| GSK Clinical Trials Call Center | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00043888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2013 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00043888 live on ClinicalTrials.gov.